Literature DB >> 12699375

Differential binding modes of diacylglycerol (DAG) and DAG lactones to protein kinase C (PK-C).

Dina M Sigano1, Megan L Peach, Kassoum Nacro, Yongseok Choi, Nancy E Lewin, Marc C Nicklaus, Peter M Blumberg, Victor E Marquez.   

Abstract

Diacylglycerol lactones (DAG lactones), analogous to highly potent diacylglycerols (DAGs) were synthesized to demonstrate the ability of PK-C to discriminate between two differential binding modes, sn-1 and sn-2. While both sn-1 and sn-2 binding modes are allowable in terms of hydrogen bonding, it has been found that in general, DAGs prefer to bind sn-1, while the corresponding analogous DAG lactones prefer to bind sn-2. However, this binding orientation can be directly influenced by the disposition and nature of the acyl substituent, particularly if it is highly branched. When the "binding driving force" (i.e., the larger branched acyl chain) is in the sn-2 position, a dramatic increase in binding affinity is observed in the DAG lactone as compared to its open chain DAG counterpart. As these analogous DAGs and DAG lactones have almost identical log P values, this difference in binding affinity is a direct result of the entropic advantage of constraining the glycerol backbone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699375     DOI: 10.1021/jm020476o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities.

Authors:  Dehui Duan; Dina M Sigano; James A Kelley; Christopher C Lai; Nancy E Lewin; Noemi Kedei; Megan L Peach; Jeewoo Lee; Thushara P Abeyweera; Susan A Rotenberg; Hee Kim; Young Ho Kim; Saïd El Kazzouli; Jae-Uk Chung; Howard A Young; Matthew R Young; Alyson Baker; Nancy H Colburn; Adriana Haimovitz-Friedman; Jean-Philip Truman; Damon A Parrish; Jeffrey R Deschamps; Nicholas A Perry; Robert J Surawski; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2008-08-13       Impact factor: 7.446

2.  Conformationally constrained analogues of diacylglycerol (DAG). 25. Exploration of the sn-1 and sn-2 carbonyl functionality reveals the essential role of the sn-1 carbonyl at the lipid interface in the binding of DAG-lactones to protein kinase C.

Authors:  Ji-Hye Kang; Megan L Peach; Yongmei Pu; Nancy E Lewin; Marc C Nicklaus; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2005-09-08       Impact factor: 7.446

3.  Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRP.

Authors:  Lia C Garcia; Lucia Gandolfi Donadío; Ella Mann; Sofiya Kolusheva; Noemi Kedei; Nancy E Lewin; Colin S Hill; Jessica S Kelsey; Jing Yang; Timothy E Esch; Marina Santos; Megan L Peach; James A Kelley; Peter M Blumberg; Raz Jelinek; Victor E Marquez; Maria J Comin
Journal:  Bioorg Med Chem       Date:  2014-04-20       Impact factor: 3.641

4.  Synthetic caged DAG-lactones for photochemically controlled activation of protein kinase C.

Authors:  Wataru Nomura; Tetsuo Narumi; Nami Ohashi; Yuki Serizawa; Nancy E Lewin; Peter M Blumberg; Toshiaki Furuta; Hirokazu Tamamura
Journal:  Chembiochem       Date:  2011-01-18       Impact factor: 3.164

5.  Rational design of drugs that induce human immunodeficiency virus replication.

Authors:  Dean H Hamer; Sven Bocklandt; Louise McHugh; Tae-Wook Chun; Peter M Blumberg; Dina M Sigano; Victor E Marquez
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Synthesis and Evaluation of Dimeric Derivatives of Diacylglycerol-Lactones as Protein Kinase C Ligands.

Authors:  Nami Ohashi; Ryosuke Kobayashi; Wataru Nomura; Takuya Kobayakawa; Agnes Czikora; Brienna K Herold; Nancy E Lewin; Peter M Blumberg; Hirokazu Tamamura
Journal:  Bioconjug Chem       Date:  2017-07-21       Impact factor: 4.774

7.  Agonist-induced Ca2+ entry determined by inositol 1,4,5-trisphosphate recognition.

Authors:  Damian B van Rossum; Randen L Patterson; Kirill Kiselyov; Darren Boehning; Roxanne K Barrow; Donald L Gill; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

Review 8.  Wealth of opportunity - the C1 domain as a target for drug development.

Authors:  P M Blumberg; N Kedei; N E Lewin; D Yang; G Czifra; Y Pu; M L Peach; V E Marquez
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

Review 9.  Structural insights into C1-ligand interactions: Filling the gaps by in silico methods.

Authors:  Sachin Katti; Tatyana I Igumenova
Journal:  Adv Biol Regul       Date:  2021-01-18

10.  Diacylglycerol lactones targeting the structural features that distinguish the atypical C1 domains of protein kinase C ζ and ι from typical C1 domains.

Authors:  Yongmei Pu; Ji-Hye Kang; Dina M Sigano; Megan L Peach; Nancy E Lewin; Victor E Marquez; Peter M Blumberg
Journal:  J Med Chem       Date:  2014-04-17       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.